Acipimox Acutely Increases GLP-1 Concentrations in Overweight Subjects and Hypopituitary Patients. [electronic resource]
Producer: 20200527Description: 2581-2592 p. digitalISSN:- 1945-7197
- Adult
- Animals
- Blood Glucose -- analysis
- Cells, Cultured
- Cross-Over Studies
- Enteroendocrine Cells -- drug effects
- Fatty Acids, Nonesterified -- metabolism
- Glucagon-Like Peptide 1 -- metabolism
- Glucose Tolerance Test
- Humans
- Hypolipidemic Agents -- administration & dosage
- Hypopituitarism -- blood
- Insulin Resistance
- Intestinal Mucosa -- cytology
- Lipolysis -- drug effects
- Male
- Middle Aged
- Overweight -- blood
- Pilot Projects
- Primary Cell Culture
- Pyrazines -- administration & dosage
- Rats
No physical items for this record
Publication Type: Journal Article; Pragmatic Clinical Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.